Expression of Fas ligand (FasL) renders certain tissues immune privileged, but its expression in other tissues can result in severe neutrophil infiltration and tissue destruction. The consequences of enforced FasL expression in striated muscle is particularly controversial. To create a stable reproducible pattern of cardiomyocyte-specific FasL expression, transgenic (Tg) mice were generated that express murine FasL specifically in the heart, where it is not normally expressed. Tg animals are healthy and indistinguishable from nontransgenic littermates. FasL expression in the heart does result in mild leukocyte infiltration, but despite coexpression of Fas and FasL in Tg hearts, neither myocardial tissue apoptosis nor necrosis accompanies the leukocyte infiltration. Instead of tissue destruction, FasL Tg hearts develop mild interstitial fibrosis, functional changes, and cardiac hypertrophy, with corresponding molecular changes in gene expression. Induced expression of the cytokines TNF-α, IL-1β, IL-6, and TGF-β accompanies these proinflammatory changes. The histologic, functional, and molecular proinflammatory consequences of cardiac FasL expression are transgene-dose dependent. Thus, coexpression of Fas and FasL in the heart results in leukocyte infiltration and hypertrophy, but without the severe tissue destruction observed in other examples of FasL-directed proinflammation. The data suggest that the FasL expression level and other tissue-specific microenvironmental factors can modulate the proinflammatory consequences of FasL.
David P. Nelson, Elizabeth Setser, D. Greg Hall, Steven M. Schwartz, Timothy Hewitt, Raisa Klevitsky, Hanna Osinska, Don Bellgrau, Richard C. Duke, Jeffrey Robbins
Title and authors | Publication | Year |
---|---|---|
Comparison of Cardioplegic Solutions in Coronary Bypass Surgery Over Autophagy and Apoptosis Mechanisms.
Sener EF, Hamurcu Z, Taheri S, Tahtasakal R, Delibasi N, Elcik D, Mehmetbeyoglu E, Tuncay A, Dal F, Bayram KK, Gunes I, Emirogullari ON |
Arquivos brasileiros de cardiologia | 2023 |
Biomarker profiles in obesity patients and their relation to cardiac dysfunction
SM Snelder, N Pouw, Y Aga, MC Cabezas, F Zijlstra, I Kardys, BM van Dalen |
Biomarkers in Medicine | 2021 |
Toxic effects and molecular mechanism of doxorubicin on different organs – an update
K Renu, LP Pureti, B Vellingiri, AV Gopalakrishnan |
Toxin Reviews | 2021 |
Genome Wide Meta-Analysis identifies common genetic signatures shared by heart function and Alzheimer’s disease
ME Sáez, A González-Pérez, B Hernández-Olasagarre, A Beà, S Moreno-Grau, I de Rojas, G Monté-Rubio, A Orellana, S Valero, JX Comella, D Sanchís, A Ruiz |
Scientific Reports | 2019 |
Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4+ T-cell mediated rejection
RJ Plenter, TJ Grazia, DP Nelson, MR Zamora, RG Gill, BA Pietra |
Cellular Immunology | 2015 |
Diabetic Cardiovascular Disease Induced by Oxidative Stress
Y Kayama, U Raaz, A Jagger, M Adam, I Schellinger, M Sakamoto, H Suzuki, K Toyama, J Spin, P Tsao |
International journal of molecular sciences | 2015 |
TWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac Failure
T Novoyatleva, A Sajjad, FB Engel |
Frontiers in immunology | 2014 |
Arachidonate 12/15-Lipoxygenase–Induced Inflammation and Oxidative Stress Are Involved in the Development of Diabetic Cardiomyopathy
H Suzuki, Y Kayama, M Sakamoto, H Iuchi, I Shimizu, T Yoshino, D Katoh, T Nagoshi, K Tojo, T Minamino, M Yoshimura, K Utsunomiya |
Diabetes | 2014 |
A Novel Role for SIRT-1 in L-Arginine Protection against STZ Induced Myocardial Fibrosis in Rats
SM Rizk, SA El-Maraghy, NN Nassar, DK Singla |
PloS one | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Tumor Necrosis Factor Receptor–Associated Factor 2 Signaling Provokes Adverse Cardiac Remodeling in the Adult Mammalian Heart
VG Divakaran, S Evans, VK Topkara, A Diwan, J Burchfield, F Gao, J Dong, HP Tzeng, N Sivasubramanian, PM Barger, DL Mann |
Circulation. Heart failure | 2013 |
Cardiomyocyte apoptosis in the failing heart — A critical review from definition and classification of cell death
G Takemura, M Kanoh, S Minatoguchi, H Fujiwara |
International Journal of Cardiology | 2013 |
TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure
T Ueland, A Yndestad, CP Dahl, L Gullestad, P Aukrust |
Current Heart Failure Reports | 2012 |
Pre-existing fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of fasl expression after inoculation facilitates tumor formation
HY Chiu, GH Sun, SY Chen, HH Wang, MY Ho, CY Chu, WL Wu, RS Jhou, YL Tsai, RT Huang, KH Sun, SJ Tang |
Molecular Carcinogenesis | 2012 |
Protective effect of Tranilast on radiation-induced heart fibrosis in C57BL/6 mouse
S Moon |
International Journal of Contents | 2012 |
Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis
S Miyata, G Takemura, KI Kosai, T Takahashi, M Esaki, L Li, H Kanamori, R Maruyama, K Goto, A Tsujimoto, T Takeyama, T Kawaguchi, T Ohno, K Nishigaki, T Fujiwara, H Fujiwara, S Minatoguchi |
The American Journal of Pathology | 2010 |
Apoptosis in Cardiovascular Diseases: Mechanism and Clinical Implications
NH Kim, PM Kang |
Korean Circulation Journal | 2010 |
Effects of Fas-ligand overexpression on alveolar type II cell growth kinetics in perinatal murine lungs
ME de Paepe, SA Haley, Z Lacourse, Q Mao |
Pediatric Research | 2010 |
Comprehensive Toxicology
JM Sands, JW Verlander |
Comprehensive Toxicology | 2010 |
Is the Fas/Fas-L Pathway a Promising Target for Treating Inflammatory Heart Disease?
A Henriques-Pons, GM de Oliveira |
Journal of Cardiovascular Pharmacology | 2009 |
The Fas system confers protection against alveolar disruption in hyperoxia-exposed newborn mice
Q Mao, S Gundavarapu, C Patel, A Tsai, FI Luks, ME de Paepe |
American journal of respiratory cell and molecular biology | 2008 |
c-Flip overexpression reduces cardiac hypertrophy in response to pressure overload
C Giampietri, S Petrungaro, M Musumeci, P Coluccia, F Antonangeli, PD Cesaris, A Filippini, G Marano, E Ziparo |
Journal of Hypertension | 2008 |
Myocardial Fas Ligand Expression Increases Susceptibility to AZT-Induced Cardiomyopathy
E Purevjav, DP Nelson, JJ Varela, S Jimenez, DL Kearney, XV Sanchez, G DeFreitas, B Carabello, MD Taylor, M Vatta, WT Shearer, JA Towbin, NE Bowles |
Cardiovascular Toxicology | 2007 |
Handbook of Systemic Autoimmune Diseases
M Karmegam, RJ Quigg |
Handbook of Systemic Autoimmune Diseases | 2007 |
Mechanisms of malignant glioma immune resistance and sources of immunosuppression
GG Gomez, CA Kruse |
Gene therapy & molecular biology | 2006 |
The tumor necrosis factor superfamily in heart failure
T Ueland, P Aukrust, JK Damas, L Gullestad, A Yndestad |
Future Cardiology | 2006 |
Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1
J Niu, A Azfer, MF Deucher, PJ Goldschmidt-Clermont, PE Kolattukudy |
Journal of Molecular and Cellular Cardiology | 2006 |
Hydrogen peroxide predisposes neonatal rat ventricular myocytes to Fas-mediated apoptosis
G Yaniv, M Shilkrut, S Larisch, O Binah |
Biochemical and Biophysical Research Communications | 2005 |
Involvement of death receptor signaling in mechanical stretch-induced cardiomyocyte apoptosis
X Liao, X Wang, Y Gu, Q Chen, LY Chen |
Life Sciences | 2005 |
Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
L Gullestad, P Aukrust |
The American Journal of Cardiology | 2005 |
Molecular Mechanisms of Cardiac Hypertrophy and Failure
W Dun, P Boyden |
Molecular Mechanisms of Cardiac Hypertrophy and Failure | 2005 |
Molecular Autoimmunity
M Zouali |
2005 | |
Nitric oxide and promotion of cardiac myocyte apoptosis
P Andréka, T Tran, KA Webster, NH Bishopric |
Molecular and Cellular Biochemistry | 2004 |
Fas ligand gene transfer to the embryonic heart induces programmed cell death and outflow tract defects
D Sallee, Y Qiu, J Liu, M Watanabe, SA Fisher |
Developmental Biology | 2004 |
Role of the Fas/Fas Ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in hepg2 cells
SH Oh, HQ Yin, BH Lee |
Archives of Pharmacal Research | 2004 |
Therapeutic Potential of Anticytokine Therapy in Congestive Heart Failure:
P Aukrust, A Yndestad, JK Dam??s, L Gullestad |
American Journal of Cardiovascular Drugs | 2004 |
Involvement of IL-17 in Fas ligand-induced inflammation
M Umemura, T Kawabe, K Shudo, H Kidoya, M Fukui, M Asano, Y Iwakura, G Matsuzaki, R Imamura, T Suda |
International Immunology | 2004 |
Bcl-2 Is a Key Factor for Cardiac Fibroblast Resistance to Programmed Cell Death
M Mayorga, N Bahi, M Ballester, JX Comella, D Sanchis |
The Journal of biological chemistry | 2004 |
The Regulation of Interleukin-6 Secretion by Prostanoids and Members of the Tumor Necrosis Factor Superfamily in Fresh Villous Fragments of Term Human Placenta
MA Turner, S Vause, SL Greenwood |
Journal of the Society for Gynecologic Investigation | 2004 |
Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS
EL Regardsoe, MM McMenamin, HM Charlton, MJ Wood |
Gene Therapy | 2004 |
Urocortin-II and Urocortin-III Are Cardioprotective against Ischemia Reperfusion Injury: An Essential Endogenous Cardioprotective Role for Corticotropin Releasing Factor Receptor Type 2 in the Murine Heart
BK Brar, AK Jonassen, EM Egorina, A Chen, A Negro, MH Perrin, OD Μjøs, DS Latchman, KF Lee, W Vale |
Endocrinology | 2004 |
Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases
PM Kang, S Izumo |
Trends in Molecular Medicine | 2003 |
Contribution of Fas to diabetes development
AY Savinov, A Tcherepanov, EA Green, RA Flavell, AV Chervonsky |
Proceedings of the National Academy of Sciences | 2003 |
Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion
QZ Feng, TD Li, LX Wei, X Qiao, J Yi, L Wang, TS Yang |
Molecular pathology : MP | 2003 |
Apoptosis and Plastic Surgery
BR Gastman, JW Futrell, EK Manders |
Plastic and Reconstructive Surgery | 2003 |
Regulation of cardiac myocyte cell death
A Clerk, SM Cole, TE Cullingford, JG Harrison, M Jormakka, DM Valks |
Pharmacology & Therapeutics | 2003 |
Apoptosis and Plastic Surgery:
BR Gastman, JW Futrell, EK Manders |
Plastic and Reconstructive Surgery | 2003 |
Endothelial Cell Overexpression of Fas Ligand Attenuates Ischemia-Reperfusion Injury in the Heart
J Yang, SP Jones, T Suhara, JJ Greer, PD Ware, NP Nguyen, H Perlman, DP Nelson, DJ Lefer, K Walsh |
The Journal of biological chemistry | 2003 |
Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo
P Lee, M Sata, DJ Lefer, SM Factor, K Walsh, RN Kitsis |
American journal of physiology. Heart and circulatory physiology | 2003 |
Fas receptor signaling inhibits GSK3beta in cardiomyocytes and is required for pressure overload-induced hypertrophy
Cornel Badorff, Hartmut Ruetten, Sven Mueller, Meike Stahmer, Doris Gehring, Frank Jung, Christian Ihling, Andreas M. Zeiher, Stefanie Dimmeler |
Journal of Clinical Investigation | 2002 |
The MEKK1-JNK pathway plays a protective role in pressure overload, but does not mediate cardiac hypertrophy
Junichi Sadoshima, Olivier Montagne, Qian Wang, Guiping Yang, Jill Warden, Jing Liu, Gen Takagi, Vijaya Karoor, Chull Hong, Gary L Johnson, Dorothy E Vatner, Stephen F Vatner |
Journal of Clinical Investigation | 2002 |
Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension
B Hocher, M Godes, J Olivier, J Weil, T Eschenhagen, T Slowinski, HH Neumayer, C Bauer, M Paul, YM Pinto |
Journal of Hypertension | 2002 |
New Insights Into the Role of Apoptosis in Cardiovascular Disease
PM Kang, P Yue, S Izumo |
Circulation Journal | 2002 |
Increased plasma levels of the soluble form of fas ligand in patients with acute myocardial infarction and unstable angina pectoris
M Shimizu, K Fukuo, S Nagata, T Suhara, M Okuro, K Fujii, Y Higashino, M Mogi, Y Hatanaka, T Ogihara |
Journal of the American College of Cardiology | 2002 |
Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3
Y Seko, N Kayagaki, K Seino, H Yagita, K Okumura, R Nagai |
Journal of the American College of Cardiology | 2002 |
Role of Fas/Fas Ligand Interaction in Ischemia-Induced Collateral Vessel Growth
M SATA, Y HIRATA, R NAGAI |
Hypertension Research | 2002 |
Tumor Necrosis Factor α Up-regulates Non-lymphoid Fas-ligand following Superantigen-induced Peripheral Lymphocyte Activation
MJ Pinkoski, NM Droin, DR Green |
The Journal of biological chemistry | 2002 |
Apoptosis and Heart Failure: Mechanisms and Therapeutic Implications
QM Chen, VC Tu |
American Journal Cardiovascular Drugs | 2002 |
Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis
MW Cunningham |
The American Journal of Pathology | 2001 |
Cardiac hypertrophy and failure: lessons learned from genetically engineered mice
Y Takeishi, RA Walsh |
Acta Physiologica Scandinavica | 2001 |
Apoptosis and its clinical impact
BR Gastman |
Head & Neck | 2001 |
Molecular mechanisms of apoptosis in the cardiac myocyte
N Bishopric |
Current Opinion in Pharmacology | 2001 |
Myocardial hypertrophy in transgenic mice overexpressing human interleukin 1α
K Isoda, Y Kamezawa, N Tada, M Sato, F Ohsuzu |
Journal of Cardiac Failure | 2001 |
Akt Like a Woman: Gender Differences in Susceptibility to Cardiovascular Disease
PH Sugden, A Clerk |
Circulation research | 2001 |
Acute and Chronic Smooth Muscle Cell Apoptosis After Mechanical Vascular Injury Can Occur Independently of the Fas-Death Pathway
M Sata, S Sugiura, M Yoshizumi, Y Ouchi, Y Hirata, R Nagai |
Arteriosclerosis, thrombosis, and vascular biology | 2001 |